Refractory pseudoseptic arthritis in Behçet's disease successfully treated with infliximab: a case report and literature review

Mod Rheumatol. 2014 Jan;24(1):199-205. doi: 10.3109/14397595.2013.852839.

Abstract

Arthritis associated with Behçet's disease is typically nonerosive and nondeforming, and most patients respond to colchicine treatment. However, destructive arthritis and refractory arthritis have also been reported on occasion. Elevated white blood cell counts may occur in synovial fluid in BD, but pseudoseptic arthritis is a very rare event in this disease. We report a patient with BD and rapidly progressive deforming pseudoseptic arthritis refractory to colchicine, corticosteroids, and methotrexate, who entered remission after infliximab treatment.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Arthritis / complications
  • Arthritis / drug therapy*
  • Behcet Syndrome / complications*
  • Humans
  • Infliximab
  • Male
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Infliximab